Profile | GDS4284 / 210242_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1339.12 | 78 |
GSM687648 | Patient 402 control | 1425 | 79 |
GSM687653 | Patient 403 control | 1515.44 | 80 |
GSM687658 | Patient 404 control | 1281.49 | 78 |
GSM687663 | Patient 411 control | 1206.67 | 77 |
GSM687668 | Patient 422 control | 1330.13 | 78 |
GSM687673 | Patient 424 control | 1184.7 | 76 |
GSM687678 | Patient 425 control | 1116.47 | 75 |
GSM687683 | Patient 427 control | 1409.39 | 79 |
GSM687688 | Patient 428 control | 1863.08 | 83 |
GSM687695 | Patient 441 control | 3007.32 | 90 |
GSM687699 | Patient 443 control | 1441.23 | 80 |
GSM687704 | Patient 444 control | 1638.26 | 81 |
GSM687707 | Patient 448 control | 1616.03 | 81 |
GSM687712 | Patient 449 control | 1507.7 | 80 |
GSM687719 | Patient 450 control | 1557.48 | 81 |
GSM687724 | Patient 451 control | 1565.85 | 81 |
GSM687728 | Patient 452 control | 1282.91 | 78 |
GSM687646 | Patient 401 treated 24h | 1405.28 | 79 |
GSM687649 | Patient 402 treated 24h | 1009.27 | 74 |
GSM687665 | Patient 411 treated 24h | 1109.42 | 75 |
GSM687651 | Patient 402 treated 4 weeks | 1366.08 | 78 |
GSM687667 | Patient 411 treated 4 weeks | 1167.42 | 76 |
GSM687670 | Patient 422 treated 24h | 1610.2 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1312.17 | 78 |
GSM687654 | Patient 403 treated 24h | 1355.96 | 79 |
GSM687675 | Patient 424 treated 24h | 1776.21 | 82 |
GSM687685 | Patient 427 treated 24h | 1489.15 | 80 |
GSM687656 | Patient 403 treated 4 weeks | 986.746 | 74 |
GSM687677 | Patient 424 treated 4 weeks | 1056.73 | 74 |
GSM687687 | Patient 427 treated 4 weeks | 1056.25 | 74 |
GSM687692 | Patient 428 treated 4h | 1440.78 | 79 |
GSM687716 | Patient 449 treated 4h | 936 | 73 |
GSM687722 | Patient 450 treated 4h | 1772.69 | 82 |
GSM687680 | Patient 425 treated 24h | 1376.21 | 78 |
GSM687690 | Patient 428 treated 24h | 1460.43 | 80 |
GSM687700 | Patient 443 treated 24h | 3448.54 | 91 |
GSM687705 | Patient 444 treated 24h | 1108.34 | 76 |
GSM687714 | Patient 449 treated 24h | 991.96 | 74 |
GSM687721 | Patient 450 treated 24h | 2179.96 | 85 |
GSM687682 | Patient 425 treated 4 weeks | 1456 | 79 |
GSM687694 | Patient 428 treated 4 weeks | 1144.05 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 1468.21 | 79 |
GSM687718 | Patient 449 treated 4 weeks | 914.435 | 73 |
GSM687723 | Patient 450 treated 4 weeks | 1780.43 | 82 |
GSM687661 | Patient 404 treated 4h | 1494.27 | 80 |
GSM687710 | Patient 448 treated 4h | 1665.77 | 82 |
GSM687726 | Patient 451 treated 4h | 1452.88 | 80 |
GSM687730 | Patient 452 treated 4h | 2973.99 | 90 |
GSM687660 | Patient 404 treated 24h | 3693.84 | 91 |
GSM687697 | Patient 441 treated 24h | 2950.13 | 89 |
GSM687709 | Patient 448 treated 24h | 1319.97 | 78 |
GSM687725 | Patient 451 treated 24h | 1692.63 | 82 |
GSM687729 | Patient 452 treated 24h | 3435.21 | 91 |
GSM687727 | Patient 451 treated 4 weeks | 1431.67 | 79 |
GSM687731 | Patient 452 treated 4 weeks | 1422.43 | 79 |